Mankind Pharma completes Rs 13,768 cr BSV acquisition

Mankind Pharma has completed the acquisition of Bharat Serums and Vaccines Ltd for Rs 13,768 crore. This acquisition strengthens Mankind Pharma's position in the Indian women's health and fertility drug market. The transaction aligns with Mankind's strategy to access high entry barrier products and complex R&D platforms, promising accelerated growth and expanded market access.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8TzXQpi
via IFTTT